Filing Details
- Accession Number:
- 0001127602-12-023646
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-02 18:36:04
- Reporting Period:
- 2012-08-01
- Filing Date:
- 2012-08-02
- Accepted Time:
- 2012-08-02 17:36:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236441 | A Robert Breyer | Connaught House 1 Burlington Road Dublin 4 Ireland | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2012-08-01 | 5,000 | $8.98 | 63,106 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2012-08-01 | 5,000 | $18.58 | 58,106 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Non Qualified Stock Option (Right to Buy) | Disposition | 2012-08-01 | 5,000 | $0.00 | 5,000 | $8.98 |
| Ordinary Shares | Non Qualified Stock Option (Right to Buy) | Acquisiton | 2012-08-01 | 25,000 | $0.00 | 25,000 | $18.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 400 | 2019-10-06 | No | 4 | M | Direct | |
| 25,000 | 2013-08-01 | 2022-08-01 | No | 4 | A | Direct |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- These options are fully vested in accordance with their terms.
- This option becomes exercisable in full one year from date of grant.
Billionaire Hedge Funds
